David E. Lazar Cyclacel Pharmaceuticals, Inc. (CYCC) insider trading activity

CYCC Quotes by TradingView

David E. Lazar is Interim CEO of Cyclacel Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of CYCC, which is worth approximately $0. The most recent transaction as insider was on Feb 26, 2025, when has been sold 194,628,820 shares (Common Stock) at a price of $0.03 per share, resulting in proceeds of $5,838,864. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

David E. Lazar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 26 2025
SELL
Open market or private sale
$5,838,864 $0.03 p/Share
194,628,820 Reduced 100.0%
0 Common Stock
Feb 26 2025
BUY
Exercise of conversion of derivative security
-
194,628,820 Added 50.0%
194,628,820 Common Stock

Also insider at

TTNP
TITAN PHARMACEUTICALS INC Healthcare
Chief Executive Officer
MINM
MINIM, INC. Technology
Director
OPGN
OPGEN INC Healthcare
Chief Executive Officer
LQR
LQR House Inc.
President
DEL

David E. Lazar

Interim CEO
Dubai, C0

Track Institutional and Insider Activities on CYCC

Follow Cyclacel Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCC shares.

Notify only if

Insider Trading

Get notified when an Cyclacel Pharmaceuticals, Inc. insider buys or sells CYCC shares.

Notify only if

News

Receive news related to Cyclacel Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYCC